PL323867A1 - Cells line producing analgesic compounds for relieving pains - Google Patents

Cells line producing analgesic compounds for relieving pains

Info

Publication number
PL323867A1
PL323867A1 PL96323867A PL32386796A PL323867A1 PL 323867 A1 PL323867 A1 PL 323867A1 PL 96323867 A PL96323867 A PL 96323867A PL 32386796 A PL32386796 A PL 32386796A PL 323867 A1 PL323867 A1 PL 323867A1
Authority
PL
Poland
Prior art keywords
line producing
cells line
analgesic compounds
relieving pains
producing analgesic
Prior art date
Application number
PL96323867A
Other languages
English (en)
Inventor
Joel Saydoff
Shou Wong
Original Assignee
Cytotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytotherapeutics Inc filed Critical Cytotherapeutics Inc
Publication of PL323867A1 publication Critical patent/PL323867A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL96323867A 1995-06-07 1996-06-07 Cells line producing analgesic compounds for relieving pains PL323867A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
PL323867A1 true PL323867A1 (en) 1998-04-27

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96323867A PL323867A1 (en) 1995-06-07 1996-06-07 Cells line producing analgesic compounds for relieving pains

Country Status (20)

Country Link
EP (1) EP0833935A1 (enrdf_load_stackoverflow)
JP (1) JPH11507530A (enrdf_load_stackoverflow)
KR (1) KR19990022414A (enrdf_load_stackoverflow)
CN (1) CN1192246A (enrdf_load_stackoverflow)
AR (1) AR004494A1 (enrdf_load_stackoverflow)
AU (1) AU6263696A (enrdf_load_stackoverflow)
BR (1) BR9608746A (enrdf_load_stackoverflow)
CA (1) CA2223246A1 (enrdf_load_stackoverflow)
CZ (1) CZ392497A3 (enrdf_load_stackoverflow)
EE (1) EE9700326A (enrdf_load_stackoverflow)
HU (1) HUP9901191A2 (enrdf_load_stackoverflow)
IL (1) IL122415A0 (enrdf_load_stackoverflow)
IN (1) IN181898B (enrdf_load_stackoverflow)
IS (1) IS4628A (enrdf_load_stackoverflow)
NO (1) NO975545L (enrdf_load_stackoverflow)
PL (1) PL323867A1 (enrdf_load_stackoverflow)
SK (1) SK167997A3 (enrdf_load_stackoverflow)
TR (1) TR199701520T1 (enrdf_load_stackoverflow)
WO (1) WO1996040959A1 (enrdf_load_stackoverflow)
ZA (1) ZA964880B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028449A2 (en) * 1997-11-28 1999-06-10 Medical Research Council Yac vectors
WO2000016799A1 (en) * 1998-09-23 2000-03-30 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of treating chronic pain
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
ATE312916T1 (de) * 1998-10-27 2005-12-15 Anticancer Inc Herstellung eines retrovirus, welches den mel- lokus von streptomyces enthält, sowie dessen expression in säugetierzellen
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
NZ547767A (en) 2003-12-24 2010-05-28 Inst Medical W & E Hall Therapeutic agents and uses therefor
EP1766389A4 (en) 2004-05-12 2008-08-27 Inst Medical W & E Hall METHOD OF ISOLATING CELLS
DK2407484T3 (en) 2005-06-24 2016-09-05 The Walter And Eliza Hall Inst Of Medical Res Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those
CA2657532C (en) 2006-07-18 2019-06-18 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
EP3003344B1 (en) 2013-05-31 2020-11-25 University of Utah Research Foundation Conotoxin peptides, pharmaceutical compositions and uses thereof
JP6877419B2 (ja) 2015-10-27 2021-05-26 ザ ユニバーシティー オブ クイーンズランド 治療の方法およびそのために有用な剤
CN107964047B (zh) * 2017-12-18 2018-11-02 哈尔滨工业大学 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) * 2021-03-26 2021-06-04 河北医科大学 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179350A3 (en) * 1993-08-12 2003-01-02 Cytotherapeutics, Inc. Encapsulated cell system for implantation into the human CNS

Also Published As

Publication number Publication date
IL122415A0 (en) 1998-06-15
BR9608746A (pt) 1999-05-11
TR199701520T1 (xx) 1998-04-21
CA2223246A1 (en) 1996-12-19
AU6263696A (en) 1996-12-30
SK167997A3 (en) 1998-05-06
NO975545L (no) 1998-02-04
EE9700326A (et) 1998-06-15
ZA964880B (en) 1997-01-07
CZ392497A3 (cs) 1998-12-16
NO975545D0 (no) 1997-12-02
IS4628A (is) 1997-12-04
WO1996040959A1 (en) 1996-12-19
KR19990022414A (ko) 1999-03-25
AR004494A1 (es) 1998-12-16
IN181898B (enrdf_load_stackoverflow) 1998-10-24
HUP9901191A2 (hu) 1999-08-30
CN1192246A (zh) 1998-09-02
EP0833935A1 (en) 1998-04-08
JPH11507530A (ja) 1999-07-06

Similar Documents

Publication Publication Date Title
AU3213495A (en) Knock down foundation for a bed
GB9520822D0 (en) Therapeutically active compounds
IL124996A0 (en) Compounds with analgesic effect
PL326353A1 (en) Pharmaceutically active quinozolinic compounds
PL323867A1 (en) Cells line producing analgesic compounds for relieving pains
AU6239796A (en) Apparatus for relieving back pain
ZA961974B (en) Sertoli cells as neurorecovery including cells for neuro-degenerative disorders
HRP960375B1 (en) Therapeutically active compounds
AU6130196A (en) Cell treatment
GB9526511D0 (en) Pharmaceutically active compounds
IL124997A0 (en) Compounds with analgesic effect
AU5010196A (en) Therapeutic benzoxazoles
AUPN069095A0 (en) Therapeutic compounds
AUPN069195A0 (en) Therapeutic compounds
AUPN090295A0 (en) Therapeutic compounds
AUPN228095A0 (en) Therapeutic compounds
HK1014961A (en) Therapeutic compounds
GB9520845D0 (en) Therapeutically active compounds
GB9504925D0 (en) Process for preparing analgesic agents
GB9505677D0 (en) Pharmaceutically active compounds
GB9502229D0 (en) Pharmaceutically active compounds
GB9510461D0 (en) Pharmaceutically active compounds
GB9510468D0 (en) Pharmaceutically active compounds
GB9513686D0 (en) Pharmaceutically active compounds
GB9513745D0 (en) Pharmaceutically active compounds